Caitlin Farabaugh

Physician · Main Line Health

Credentials: · · · · ·

History

Main Line Health
2025–Present

Gynecologic Oncology
University of Pennsylvania Health System
2012–2015
Obstetrics and Gynecology
University of Colorado School of Medicine
2008–2012
Geisel School of Medicine at Dartmouth
2004–2008

Research

Phase I Study of Lentiviral-Transduced Chimeric Antigen Receptor-Modified T Cells Recognizing Mesothelin in Advanced Solid Cancers
Molecular Therapy · 2019 · 323 citations
Mesothelin as a target for chimeric antigen receptor-modified T cells as anticancer therapy
Review · Immunotherapy · 2016 · 66 citations
Possible Compartmental Cytokine Release Syndrome in a Patient With Recurrent Ovarian Cancer After Treatment With Mesothelin-targeted CAR-T Cells
Case report · Journal of Immunotherapy · 2017 · 61 citations

Janos Tanyi
4 papers
Mark O'Hara
3 papers
Andrew Haas
2 papers
Carl June
2 papers
Mark Morgan
2 papers
Amalia Brawley
1 paper · 1 as a fellow
Ashley Haggerty
1 paper · 1 as a fellow
CM
Casey Moffitt
1 paper · 1 as a resident
David Porter
1 paper
David Shalowitz
1 paper · 1 as a fellow
Edmund Moon
1 paper
EP
Edward Podczaski
1 paper

Clinical trials

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2022–2027